Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study.
Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study
Caminati, Marco;Padoan, Roberto;
2022-01-01
Abstract
Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
sequential rituximab 1769.full.pdf
accesso aperto
Licenza:
Non specificato
Dimensione
653.69 kB
Formato
Adobe PDF
|
653.69 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
